BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Khandelwal R, Dassanayake AS, Conjeevaram HS, Singh SP. Non-alcoholic fatty liver disease in diabetes: When to refer to the hepatologist? World J Diabetes 2021; 12(9): 1479-1493 [PMID: 34630901 DOI: 10.4239/wjd.v12.i9.1479]
URL: https://www.wjgnet.com/2220-3249/full/v12/i9/1479.htm
Number Citing Articles
1
Irene Caruso, Nicola Marrano, Giuseppina Biondi, Valentina Annamaria Genchi, Rossella D'Oria, Gian Pio Sorice, Sebastio Perrini, Angelo Cignarelli, Annalisa Natalicchio, Luigi Laviola, Francesco Giorgino. Glucagon in type 2 diabetes: Friend or foe?Diabetes/Metabolism Research and Reviews 2023; 39(3) doi: 10.1002/dmrr.3609
2
Ariel Jaffe, Tamar H. Taddei, Edoardo G. Giannini, Ysabel C. Ilagan‐Ying, Massimo Colombo, Mario Strazzabosco. Holistic management of hepatocellular carcinoma: The hepatologist's comprehensive playbookLiver International 2022; 42(12): 2607 doi: 10.1111/liv.15432
3
J. Fu, Z. Mu, L. Sun, X. Gao, X. Hu, S. Xiu. Chinese patients with type 2 diabetes mellitus and nonalcoholic fatty liver disease have lower serum osteocalcin levels compared to individuals with type 2 diabetes mellitus and no liver disease: a single-center cross-sectional studyJournal of Endocrinological Investigation 2022; 45(12): 2275 doi: 10.1007/s40618-022-01861-z
4
Guo-heng Zhang, Tian-hao Yuan, Zhen-sheng Yue, Lin Wang, Guo-Rui Dou. The presence of diabetic retinopathy closely associated with the progression of non-alcoholic fatty liver disease: A meta-analysis of observational studiesFrontiers in Molecular Biosciences 2022; 9 doi: 10.3389/fmolb.2022.1019899
5
Chun-Sik Bae, Youngchan Lee, Taeho Ahn. Therapeutic treatments for diabetes mellitus-induced liver injury by regulating oxidative stress and inflammationApplied Microscopy 2023; 53(1) doi: 10.1186/s42649-023-00089-2
6
Tanawan Kongmalai, Varalak Srinonprasert, Thunyarat Anothaisintawee, Pinkawas Kongmalai, Gareth McKay, John Attia, Ammarin Thakkinstian. New anti-diabetic agents for the treatment of non-alcoholic fatty liver disease: a systematic review and network meta-analysis of randomized controlled trialsFrontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1182037
7
Yusuf Aksu, Ali Ugur Uslu, Gulten Tarhan, Şaban Tiryaki. Renal Artery Resistive Index and Estimated Glomerular Filtration Rate in Patients with Non-alcoholic Fatty Liver DiseaseCurrent Medical Imaging Reviews 2022; 18(12): 1318 doi: 10.2174/1573405618666220516123519
8
Ioanna Papagiouvanni, Marieta P. Theodorakopoulou, Pantelis A. Sarafidis, Emmanouil Sinakos, Ioannis Goulis. Peripheral endothelial and microvascular damage in liver cirrhosis: A systematic review and meta‐analysisMicrocirculation 2022; 29(4-5) doi: 10.1111/micc.12773
9
D. Mounika Mellemputi, Hemanth Harish. Assessment of Non-Alcoholic Fatty Liver Disease as Risk Factor for Cardiovascular DiseaseIndian Journal of Cardiovascular Disease in Women 2023; 8: 230 doi: 10.25259/IJCDW_23_2022
10
Donna R Cryer. The Global Liver Institute "Liver Health is Public Health" InitiativeEuropean Endocrinology 2023; 19(2): 3 doi: 10.17925/EE.2023.19.2.3
11
Zhihua Ren, Samuel Kumi Okyere, Lei Xie, Juan Wen, Jiayi Wang, Zhengli Chen, Xueqin Ni, Junliang Deng, Yanchun Hu. Oral Administration of Bacillus toyonensis Strain SAU-20 Improves Insulin Resistance and Ameliorates Hepatic Steatosis in Type 2 Diabetic MiceFrontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.837237
12
Ehsan Amini-Salehi, Soheil Hassanipour, Mohammad-Hossein Keivanlou, Milad Shahdkar, Mahdi Orang Goorabzarmakhi, Azin Vakilpour, Farahnaz Joukar, Mohammad Hashemi, Nazila Sattari, Mohammadreza Javid, Fariborz Mansour-Ghanaei. The impact of gut microbiome-targeted therapy on liver enzymes in patients with nonalcoholic fatty liver disease: an umbrella meta-analysisNutrition Reviews 2023;  doi: 10.1093/nutrit/nuad086